-
COVID-19 health concern continues to decline in November: Poll
Pharmaceutical-Technology
December 07, 2021
The health concern over COVID-19 declined for the third consecutive month in November, shows the COVID-19 concern index, which is measured by responses to an ongoing poll Verdict launched in March 2020.
-
Omicron Variant May Overcome Prior COVID-19 Infection
Drugs
December 06, 2021
People who have already had COVID-19 have a higher risk of reinfection with the omicron coronavirus variant than with earlier variants, new research shows.
-
Omicron May Overcome Prior COVID Infection
Drugs
December 06, 2021
People who've already had COVID-19 have a higher risk of reinfection with the Omicron coronavirus variant than with earlier variants, new research shows.
-
Novavax says it could start making Omicron-specific vaccine in January
expresspharma
December 03, 2021
Other vaccine makers including Moderna and Pfizer have also begun working on Omicron-tailored COVID-19 shots.
-
UK orders extra 114 million COVID-19 vaccines to combat Omicron
PharmaTimes
December 03, 2021
Scientists and health experts have cautioned that the new variant could have the ability to bypass the effectiveness of vaccines that are currently available.
-
Second Omicron Case Reported in Man Who Traveled to NYC Anime Convention
Drugs
December 03, 2021
Just one day after the first Omicron case was reported in the United States, federal officials announced a second case on Thursday, this time in a Minnesota man who had traveled to an Anime convention in New York City in November.
-
Oravax Medical to test triple antigen oral vaccine against Omicron
Pharmaceutical-Technology
December 03, 2021
Indian biotechnology firm Premas Biotech’s joint venture company Oravax Medical is set to begin testing their triple antigen oral vaccine candidate against the new Omicron variant of concern.
-
CDC to Toughen COVID-19 Testing for International Travelers
Drugs
December 02, 2021
As the world struggles with ways to stem the spread of the new omicron variant, the U.S. Centers of Disease Control and Prevention announced Tuesday that international travelers to the United States...
-
Pharma companies research whether vaccines need upgrade to fight Omicron variant
CPhIonline
December 02, 2021
It could take pharmaceutical companies months to tweak their COVID-19 vaccines to provide sufficient protection against the Omicron variant of the coronavirus if it poses a risk of serious illness.
-
First U.S. Omicron Case Reported in California
Drugs
December 02, 2021
The first confirmed U.S. case of the Omicron variant has been reported in California, the U.S. Centers for Disease Control and Prevention announced Wednesday.